[SCHEDULE 13G/A Amendment No. 8 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
[SCHEDULE 13G/A Amendment No. 8 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a]
[THIS DEED OF SETTLEMENT is made the 15 th day of December 2014 between: 1. China Cord Blood Corporation, a company incorporated in the Cayman Islands with limited liability (Company Registration No. CT-227732) and whose shares are listed on the NYSE (hereinafter referred to as the Settlor) of the one part; and 2. Magnum Opus International (PTC) Limited, a company] [To: The Directors of China Cord Blood Corporation (the Company) Dear Sirs, Application for Shares We apply for and request you to allot and issue to us 7,080,000 shares of the Company at par value of US$0.0001 each (the Shares). In consideration for the issue of the Shares, we hereby agree and undertake to pay on demand US$708 to the] []
[China Cord Blood Corporation Announces Results of 201 4 Annual General Meeting HONG KONG, China, December 11 , 201 4 - China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 201 4 Annual General Meeting,] [FORM 6-K 4 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On December 1 1 , 201 4]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015 2Q15 Added 15,584 New Subscribers 2Q15 Revenue Up 7.4% YOY to RMB152.1 Million ($24.8 Million) 2Q15 Operating Income Increased to RMB57.5 Million ($9.4 Million) Conference Call to be Held November 26, 2014 at 8:00 a.m. ET HONG KONG, China, November 25, 2014 ] [EXPLANATORY NOTE Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months and six months ended September 30, 2014 of the Company. CHINA CORD BLOOD CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of March 31 and September 30, 2014]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015 2Q15 Added 15,584 New Subscribers 2Q15 Revenue Up 7.4% YOY to RMB152.1 Million ($24.8 Million) 2Q15 Operating Income Increased to RMB57.5 Million ($9.4 Million) Conference Call to be Held November 26, 2014 at 8:00 a.m. ET HONG KONG, China, November 25, 2014 ] [EXPLANATORY NOTE Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months and six months ended September 30, 2014 of the Company. CHINA CORD BLOOD CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of March 31 and September 30, 2014]
[1933 ACT 1933 ACT 1933 ACT 1933 ACT 1933 ACT CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$25,000,000 FOR VALUE RECEIVED, Company Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the 27 . The following] [1933 ACT 1933 ACT 1933 ACT 1933 ACT 1933 ACT CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$25,000,000 FOR VALUE RECEIVED, Company Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the 27 . The following] [Agreement Company Investor New Holders November 10, 2014 . Defined terms used but not defined herein shall have the meanings ascribed to them in the Agreement. Each New Holder hereby agrees to become a party to the Agreement and be fully bound by, and subject to, all of the terms and conditions of the Agreement as though an original party] []
[1933 ACT 1933 ACT 1933 ACT 1933 ACT 1933 ACT CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$25,000,000 FOR VALUE RECEIVED, Company Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the 27 . The following] [1933 ACT 1933 ACT 1933 ACT 1933 ACT 1933 ACT CHINA CORD BLOOD CORPORATION 7% SENIOR CONVERTIBLE NOTE Original Principal Amount: US$25,000,000 FOR VALUE RECEIVED, Company Holder Principal and Issuance Date and Note Notes Other Notes Registration Rights Agreement China Cord Blood Corporation, an exempted company with limited liability incorporated in the Cayman Islands (the 27 . The following] [Agreement Company Investor New Holders November 10, 2014 . Defined terms used but not defined herein shall have the meanings ascribed to them in the Agreement. Each New Holder hereby agrees to become a party to the Agreement and be fully bound by, and subject to, all of the terms and conditions of the Agreement as though an original party] []
[CHINA CORD BLOOD CORPORATION (Incorporated in the Cayman Islands with limited liability) (NYSE Ticker: CO) 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. NOTICE OF ANNUAL GENERAL MEETING to Be Held on December 11, 2014 (or any adjourned or postponed meeting thereof) To the Shareholders of China Cord Blood Corporation: NOTICE IS HEREBY GIVEN] [FORM 6-K CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events Where to Find Additional Information]
[EXECUTION VERSION SECURITY AGREEMENT Agreement Borrower Lender THIS SECURITY AGREEMENT (this Facility Agreement Target Accordingly, the parties hereto agree as follows: SECTION 1 Definitions; Interpretation . (a) Terms Defined in Facility Agreement . All capitalized terms used in this Agreement (including in the recitals hereof) and not otherwise defined herein shall have the meanings assigned to them in the] [EXECUTION COPY DATED THIS 17TH DAY OF OCTOBER 2014 MAGNUM OPUS INTERNATIONAL HOLDINGS LIMITED as Chargor and CORDLIFE GROUP LIMITED as Lender ACCOUNTS CHARGE WONGPARTNERSHIP LLP 12 Marina Boulevard Level 28 TABLE OF CONTENTS CLAUSE HEADING PAGE 1. INTERPRETATION 1 2. UNDERTAKING TO PAY 2 3. ACCOUNTS CHARGE 2] []
